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Time to antibiotic therapy and outcome in
bacterial meningitis: a Danish population-
based cohort study
Jacob Bodilsen1,2*, Michael Dalager-Pedersen1, Henrik Carl Schønheyder3,4 and Henrik Nielsen1,4
Abstract
Background: Community-acquired bacterial meningitis (CABM) is a life-threatening disease and timing of
antibiotic therapy remains crucial. We aimed to analyse the impact of antibiotic timing on the outcome of
CABM in a contemporary cohort.
Methods: We conducted a population-based cohort study based on chart reviews of all adult cases (>16 years of age)
of CABM in North Denmark from 1998 to 2014 excluding patients given pre-hospital parenteral antibiotics. We used
modified Poisson regression analyses to compute the adjusted risk ratio (adj. RR) with 95 % confidence intervals (CIs)
for in-hospital mortality and unfavourable outcome at discharge by time after arrival to hospital to adequate antibiotic
therapy.
Results: We identified 195 adults with CABM of whom 173 patients were eligible for further analyses. The median
door-to-antibiotic time was 2.0 h (interquartile range (IQR) 1.0–5.5). We observed increased adjusted risk ratios for
in-hospital mortality of 1.6 (95 % CI 0.8–3.2) and an unfavourable outcome at discharge of 1.5 (95 % CI 1.0–2.2,
p = 0.03) when treatment delays exceeded 6 h versus treatment within 2 h of admission. These findings
corresponded to adjusted risk ratios of in-hospital mortality of 1.1 per hour of delay (95 % CI 0.8–1.5) and an
unfavourable outcome at discharge of 1.1 per hour of delay (95 % CI 1.0–1.3) within the first 6 h of admission.
Some patients (31 %) were diagnosed after admission and had more delays in antibiotic therapy and correspondingly
increased in-hospital mortality (30 vs 14 %, p = 0.01) and unfavourable outcome (62 vs 37 %, p = 0.002).
Conclusions: Delay in antibiotic therapy was associated with unfavourable outcome at discharge.
Keywords: Bacterial meningitis, Antibiotic therapy, Outcome
Background
Community-acquired bacterial meningitis (CABM) is a
devastating disease with substantial morbidity and mortal-
ity despite treatment with modern antibiotics, advanced
intensive care and adjuvant dexamethasone treatment
[1, 2]. Thus far, attempts to further improve outcome,
including supplemental treatment with glycerol and in-
duced hypothermia, have failed [3–6].
Therefore, timing of initiation of antibiotic therapy in
CABM and potential consequences of delays remains a
topic of major interest. Some studies addressing door-
to-antibiotic time have had inconclusive results, but
most reports suggest more unfavourable outcomes with
delayed antibiotic administration [7–12]. However, the
two most cited studies were based on study populations
from 1990-2002 and 2002–2004, respectively, and they
consisted of relatively small cohorts in the era prior to
standard use of adjuvant dexamethasone therapy [11,
12]. To our understanding, these studies did not account
for whether any patients were treated with parenteral
antibiotics before admission, which has been associated
with a high mortality elsewhere [13, 14]. Moreover, these
studies did not specify if patients were diagnosed at
admission to the emergency department or later. This
could confound analyses of delays in antibiotic therapy
and outcome as these patients may have increased
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mortality and morbidity due to other reasons, e.g. pre-
dominance of different bacterial aetiologies, impaired
immunological response, comorbidity etc. Therefore,
timing of antibiotic therapy and outcome needs fur-
ther clarification in a contemporary cohort.
We conducted a retrospective study of adult patients
with CABM in North Denmark over the last 17 years
with the aim of examining time to antibiotic therapy and
outcome.
Methods
Setting
We carried out a population-based cohort study in patients
with CABM from 1 January 1998 to 31 December 2014 in
North Denmark Region. The catchment population was ap-
proximately 500,000 in 1998 and approximately 580,000 in
2014 [15]. In Denmark, primary health-care and hospital
care are tax-paid and free of charge. A unique personal
identification number is provided to all residents at birth or
immigration and is used for all health-care contacts.
Owing to health administrative reforms, the number
of hospitals providing acute care for patients decreased
from nine in 1998 to five in 2014. The Department of
Clinical Microbiology at Aalborg University Hospital
was the sole provider of microbiological diagnostics for
every hospital in the region throughout the entire study
period. This department also kept records of specimens
sent for supplementary analyses at Statens Serum Institut,
Copenhagen.
Since 1998 local guidelines recommended intravenous
penicillin G (supplemented with gentamicin in patients
aged above 40 years) as empiric treatment for CABM
and since 2003 adjuvant dexamethasone was added. In
2009, the advised antibiotic regimen was replaced by the
combination of penicillin G and cefotaxime to all adults
according to national Danish guidelines. Throughout the
study period, cerebrospinal fluid isolates of Streptococcus
pneumoniae and Neisseria meningitidis in Denmark have
retained wildtype sensitivity to penicillin (94.7 and >99 %
of isolates, respectively), and high-level resistant isolates of
pneumococci have been rare [16, 17].
Study population
The laboratory information system (ADBakt, Autonik,
Sweden) at the Department of Clinical Microbiology,
Aalborg University Hospital, was used to identify cases
of CABM in North Denmark Region. All patients aged
over 16 years were included if they had a clinical presen-
tation strongly suggestive of CABM, including signs
such as neck stiffness, petechiae, headache, fever, confu-
sion, or impaired level of consciousness, and at least one
of the following:
1. Positive CSF culture
2. Positive blood culture and more than >10
leukocytes × 106/L in the CSF [18].
3. Presence of bacteria in Gram stain of CSF
4. Non-culture detection of bacteria in CSF by either
bacterial antigen test or 16S rRNA gene
amplification.
If a patient fulfilled multiple criteria, only the strongest
criterion was noted (1>2>3>4). Patients with concomitant
infections, e.g. endocarditis or spondylodiscitis, were in-
cluded if their initial main presentation was characteristic
of meningitis and they fulfilled one of the above inclusion
criteria.
Exclusion criteria were: cerebral abscess, hospital-
acquired bacterial meningitis as defined by the Centers
for Disease Control [19], an implanted neurosurgical de-
vice, or cases where an exact time of antibiotic treatment
or the clinical records could not be retrieved.
Data sources
The main author reviewed all patient records. Time of
arrival at hospital was retrieved from ambulance charts
or, secondarily, from registrations made by secretaries or
nurses at admission to the Emergency Department. De-
tailed information on patient history, pre-hospital anti-
biotic treatment, clinical findings, preliminary diagnoses
at admission and outcome were obtained from the am-
bulance, nurses’ and doctors’ charts. When available, let-
ters of referral from general practitioners and ambulance
records were checked for remarks indicating suspicion
of bacterial meningitis. Electronic records systems were
used to obtain timing and results of diagnostic tests, i.e.
blood tests (Labka I and Labka II, CSC, USA), microbio-
logical samples (ADBakt) and cranial imaging (Easyviz,
Karos Health, Denmark). For patients admitted to an in-
tensive care unit (ICU), observation charts of vital signs
and medical treatment were examined.
Sources for time of antibiotic therapy included doctors’,
nurses’ and ICU charts, emergency triage notes, and
manual medication administration records. These also
included the electronic medication administration systems
Theriak (TM Software, Iceland) from 2004 to 2012 and
Opus (CSC, USA) from 2012 onwards.
Time to antibiotic therapy
To obtain the time to antibiotic therapy, we prioritised
nurses’ signatures for antibiotic administration on triage
forms or on nurses’ charts or in medication administra-
tion systems – paper and electronic – unless an exact
time of treatment was specified elsewhere, e.g. in the
doctors’ charts. Time to antibiotic therapy was calculated
as time from arrival at hospital to administration of first
dose of antibiotic therapy providing coverage for the
specific bacterial aetiology and antibiogram in the given
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patient in dosages recommended for treating bacterial
meningitis.
Patient data
The criterion ‘diagnosed with meningitis at referral to
hospital’ was defined as when the referral letter from the
general practitioner or the ambulance records men-
tioned suspicion of bacterial meningitis. The criterion
‘diagnosed with bacterial meningitis at admission’ de-
notes patients listed above and/or where meningitis was
mentioned in the admission records. This also included
cases that had a lumbar puncture performed or planned
at admission and patients started on antibiotic therapy
for bacterial meningitis. All other cases were regarded as
diagnosed later.
Baseline data were collected for the day of admission
in all patients. Symptoms or clinical findings were cate-
gorised as not present if they were not mentioned in the
medical records. Adjuvant dexamethasone was regis-
tered if it was administered (10 mg four times daily for 4
days) within 1 h of intravenous antibiotic treatment. We
categorised disseminated intravascular coagulation (DIC)
at admission as thrombocytopenia (platelet count below
150 × 109/L) and an activated plasmatic coagulation
profile and/or petechiae or ecchymoses with systemic
complications. An exact Glasgow Coma Scale (GCS)
score at admission was reported in about two-thirds of
the records, and if not reported, a categorical classification
was made based on observations in the patients’ records
(GCS < 9, GCS 9–12, GCS > 12). Impaired mental status
was noted if the patient had any level of reduced con-
sciousness not explained by previous comorbidity. The
duration of hospitalisation was registered from the day of
admission to the day of discharge or transfer to a rehabili-
tation unit.
Outcome
Outcome was graded according to the Glasgow Outcome
Scale (GOS) at discharge [20]. The scores and their corre-
sponding conditions are as follows: 1, death; 2, a vegetative
state (unable to interact with the environment); 3, severe
sequelae and dependency upon others in daily life; 4,
moderate sequelae but retainment of the capability of
independent living; and 5, no – or only minor – sequelae.
A score of 5 was considered favourable and 1–4 as
unfavourable.
Statistical analysis
Categorical data were analysed using Fisher’s exact test
or the χ2 test, and continuous data were analysed using
the Mann–Whitney U-test. A two-tailed p-value <0.05
was considered significant. Because odds ratio are difficult
to interpret when events are common, we computed the
risk and risk ratio for the primary outcomes in-hospital
mortality and unfavourable outcome at discharge by time
to adequate antibiotic therapy [21]. To compute the ad-
justed risk ratios (adj. RRs) with 95 % confidence intervals
(95 % CIs), we used modified Poisson regression analyses
[22]. Due to the number of events we could only adjust
for age >65 years, GCS score at admission (GCS < 13),
and presence of hypotension (systolic blood pressure
<90 mmHg) in analyses of in-hospital mortality (33
events) with further adjustment for bacterial aetiology
(S. pneumoniae yes/no) and adjunctive dexamethasone
treatment in analyses of unfavourable outcome at dis-
charge (77 events). In regression analyses, we omitted
patients who had been treated with parenteral beta-
lactams prior to admission.
We used Stata 11.2 (StataCorp., College Station, TX)
for all analyses.
Results
We identified 195 adult cases of CABM during the study
period. In six cases we could not identify an accurate
time of the first adequate dose of antibiotics and in two
cases the patient records could not be retrieved. Another
patient had died at home and was diagnosed by a foren-
sic autopsy. Prior to admission 13 patients had been
treated by the referring general practitioners with intra-
muscular benzylpenicillin 3.0 g on suspicion of bacterial
meningitis, seven (53 %) of whom died (Additional file 1:
Table S1). Therefore, 22 patients were excluded, with
173 patients remaining for further analysis of time to
antibiotic therapy.
Baseline characteristics of the patients are presented in
Table 1 and the bacterial aetiologies are shown in
Additional file 2: Table S2. Examining all 173 patients,
the median time to antibiotic therapy was 2.0 h (IQR
1.0–5.5). We observed that increased time to antibiotic
therapy was associated with in-hospital mortality (Fig. 1a,
p = 0.04) and unfavourable outcome at discharge (Fig. 1b,
p = 0.01), reaching statistical significance when treatment
delays exceeded 6 h compared with patients treated within
2 h of admission. Adjusted risk ratios of in-hospital mor-
tality and an unfavourable outcome at discharge were 1.6
(95 % CI 0.8–3.2) and 1.5 (95 % CI 1.0–2.2, p = 0.03),
respectively, in patients treated more than 6 h after ad-
mission, using patients treated within 2 h as reference
(Table 2). These findings corresponded to an adjusted
risk ratio of in-hospital mortality of 1.1 per hour of delay
(95 % CI 0.8–1.5) and an unfavourable outcome at dis-
charge of 1.1 per hour of delay (95 % CI 1.0–1.3) during
the first 6 h of admission.
Comparing patients diagnosed immediately at admis-
sion with patients diagnosed after admission, we found a
median time to antibiotic therapy of 1.3 h (interquartile
range (IQR) 0.8–2.7) vs 8.5 h (IQR 3.9–24.5) (p < 0.001),
and correspondingly in-hospital mortality of 14 vs. 30 %
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(p = 0.01) and an unfavourable outcome at discharge of
37 vs. 62 % (p = 0.002).
Similarly, patients presenting without the meningitis
triad (fever, neck stiffness, altered mental status) had longer
door-to-antibiotic time (median 3.1 vs. 1.3 h, p < 0.001), but
no substantial differences in in-hospital mortality (16
vs. 23 %, p = 0.3) and unfavourable outcome (41 vs.
49 %, p = 0.4).
Cranial imaging before lumbar puncture was more
frequent in patients diagnosed after admission (58 vs.
24 %, p < 0.001) and was associated with a substantial
treatment delay (median door-to-antibiotics 3.1 vs.
1.5 h, p = 0.01). A trend towards increased in-hospital
mortality (26 vs 16 %, p = 0.1) and unfavourable out-
come at discharge (51 vs. 41 %, p = 0.3) was also found.
Antibiotic delay of more than 2 h after admission
in patients with a pre-hospital diagnosis of meningitis
(n = 35) showed a trend towards increased mortality
(RR 1.4; 95 % CI 0.1–14.6) and unfavourable outcome
at discharge (RR 1.2; 95 % CI 0.4–3.9). Further details
on treatment and outcome according to time of day of ad-
mission, bacterial aetiology and duration of symptoms are
available in Additional file 3: Table S3.
Discussion
In this contemporary population-based cohort study of
CABM, we observed a median time to antibiotic therapy
of 2.0 h after admission. We found a 10 % increase of
in-hospital mortality and risk for unfavourable outcomes
at discharge with each hour of delay for the first 6 h of
admission (of note the increase was non-linear for un-
favourable outcome). Antibiotic delays of more than 6 h
resulted in a 50–60 % relative increase in in-hospital
mortality and unfavourable outcome at discharge when
compared with patients receiving adequate antibiotic
therapy within 2 h of admission, although statistical sig-
nificance was not reached in adjusted analyses regarding
in-hospital mortality. When compared to patients diag-
nosed with CABM on admission, patients diagnosed
after admission had increased time to antibiotics (8.5 vs.
1.3 h, p < 0.001) and mortality (30 vs. 14 %, p = 0.01).
The median time to adequate antibiotic therapy in our
study was faster than that reported by Proulx et al. (3.8 h)
Table 1 Baseline characteristics at admission of patients with
community-acquired bacterial meningitis excluding patients
treated with pre-hospital parenteral antibiotics
Patient characteristic at admission (n = 173) Total cohort
Age (years) 58 (45–70)
Male 84 (49)
Comorbiditya 62/173 (36)
Diagnosis of meningitis suspected at referral
to hospital
35/173 (20)
Diagnosed with meningitis at admission
to hospital
120/173 (69)
Duration of symptoms (days) (n = 164) 2 (2–5)
Headache 96/119 (81)
Nausea/vomiting 87/102 (85)
Petechiae/echimoses 40/135 (30)
Neck stiffness 113/160 (71)
Focal neurological deficitb 29/130 (22)
New-onset seizures 17/173 (10)
Meningitis triad (neck stiffness, fever, impaired
mental status)
78/173 (45)
Temperature (°C) (n = 169) 38.9 (38.0–39.9)
Blood pressure, systolic (mmHg) (n = 157) 138 (119–159)
Pulse rate (bpm) (n = 156) 99 (87–116)
Glasgow Coma Score
12–15 82 (47)
9–12 61 (35)
< 9 30 (17)
C-reactive protein (mg/L) (n = 170) 211 (110–298)
Blood leukocytes (109/L) (n = 171) 17 (11–24)
Disseminated intravascular coagulopathy 31/173 (18)
CSF
Leukocytes (106/L) (n = 164) 1925 (204–6081)
Erythrocytes (106/L) (n = 164) 145 (18–593)
CSF-glucose (mmol/L) (n = 163) 0.9 (0.1–3.1)
CSF/blood glucose ratio (n = 163) 0.1 (0.01–0.4)
CSF protein (g/L) (n = 166) 3.7 (1.9–7.9)
Aetiology
S. pneumoniae 96/173 (55)
N. meningitidis 36/173 (21)
Other 41/173 (24)
Antibiotics for sepsis given before meningitis
was diagnosed
11/173 (6)
Time to antibiotic therapy for meningitis
(h, n = 173)
2.0 (1.0–5.5)
Dexamethasone treatmentc 55/116 (47)
Cranial imaging before lumbar puncture 60/173 (35)
Cranial imaging during hospitalisation 134/173 (77)
Intensive care unit admission 104/173 (60)
Table 1 Baseline characteristics at admission of patients with
community-acquired bacterial meningitis excluding patients
treated with pre-hospital parenteral antibiotics (Continued)
Unfavourable outcome (GOS 1–4) 77/173 (45)
Mortality 33/173 (19)
Binary variables are listed as n/N (%) and continuous variables as medians
(IQR). aAlcoholism, asplenia, cancer, cirrhosis, congenital or acquired
immunodeficiency including HIV, diabetes mellitus, heart failure (ejection
fraction <40 %) and renal impairment (serum creatinine >130 μmol/L).
bParaesthesia, motor or cranial nerve paresis. cPatients included after
implementation of adjunctive dexamethasone treatment in 2002
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[11] but comparable to observations in another Danish
study by Køster-Rasmussen et al. (2.0 h) [12]. Proulx et al.
observed increased case fatality (OR 8.4, 95 % CI 1.7–
40.9) when treatment delays exceeded 6 h after admission,
but without any sign of increased mortality with less delay.
Our study consistently showed an increased in-hospital
mortality and unfavourable outcome with step-wise delays
in time to antibiotic therapy underscoring the biological
rationale of the association. Similar to our study, Køster-
Rasmussen et al. also found increased unfavourable out-
comes with treatment delays (OR 1.1 per hour of delay) in
adjusted analyses, but without any report on effect on
mortality. Both studies were based on less contemporary
cohorts, included fewer adult cases (118 and 125 cases, re-
spectively), and did not specify if patients were given pre-
hospital parenteral antibiotics. Furthermore, these studies
did not account for time of diagnosis of CABM, which
had a substantial effect on antibiotic timing and outcome
in our study.
A recently published prospective Swedish observa-
tional study with 609 adult cases from 2005 to 2012 also
found a median time to antibiotic treatment of 2 h after
admission and an improved survival after an amendment
of national guidelines limiting the indications for cranial
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Fig. 1 a Time to antibiotic therapy and in-hospital mortality in community-acquired bacterial meningitis. *P-value <0.05 compared with patients
treated 0–2 h from admission. b Time to antibiotic therapy and unfavourable outcome at discharge in community-acquired bacterial meningitis.
*P-value <0.05 compared with patients treated 0–2 h from admission
Table 2 Time to adequate antibiotic therapy and risk ratios for in-hospital mortality and unfavourable outcome at discharge among
patients with community-acquired bacterial meningitis
Adequate antibiotic therapy
initiated
Risk ratio for in-hospital mortality (95 % CI) Risk ratio for unfavourable outcome (95 % CI)
Crude Adjusteda Crude Adjustedb
0–2 h after admission Ref. Ref. Ref. Ref.
2–4 h after admission 1.1 (0.5–2.8) 1.2 (0.5–2.7) 1.4 (0.9–2.2) 1.5 (0.9–2.2)
4–6 h after admission 1.4 (0.4–5.3) 1.4 (0.5–3.6) 1.1 (0.5–2.6) 1.1 (0.6–2.2)
>6 h after admission 2.1 (1.0–4.2)* 1.6 (0.8–3.2) 1.7 (1.2–2.5)* 1.5 (1.0–2.2)*
*p < 0.05. CI indicates confidence interval. aAdjusted for age >65 years, Glasgow Coma Score <13 and arterial systolic hypotension (<90 mmHg) at admission.
bAdjusted for age >65 years, Glasgow Coma Score <13, arterial systolic hypotension (<90 mmHg), bacterial aetiology (S. pneumoniae yes/no) and adjunctive
dexamethasone treatment (yes/no)
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imaging before lumbar puncture [23]. However, informa-
tion was incomplete regarding time of diagnosis and disease
severity (e.g. occurrence of seizures, signs of systemic
compromise, and CSF leukocyte count). The study also
included a few patients without a proven diagnosis of
meningitis, and the completeness of patient inclusion
varied during the study period (increasing from 60 to
80 %) [23].
Our study has both strengths and limitations when
examining time to antibiotic therapy and outcome of
CABM. The population-based design and the inclusion
of uniquely identifiable adults limited selection bias, and
the validity of the diagnoses was ensured by rigorous in-
clusion criteria comprising clinical description, CSF find-
ings and microbiological diagnostics. Moreover, we only
included cases with an exact time of antibiotic treatment
listed in the charts, although we cannot exclude random
error (e.g. inaccurate signing off of antibiotic administration
by nurses). We also accounted for patients treated with
pre-hospital parenteral antibiotics and time of diagnosis.
Several limitations inherent to a retrospective observa-
tional study exist, including incomplete data of certain
clinical characteristics (e.g. time to antibiotic therapy
and GCS score at admission in some patients). We may
also have missed a small number of blood-culture nega-
tive cases admitted at other departments without a lum-
bar puncture performed during admission. Differential
misclassification in timing of antibiotic therapy may also
be present because patients diagnosed immediately at
admission more often had an exact point of time docu-
mented in their records compared with patients with
more uncharacteristic presentations diagnosed later
during admission. Moreover, data on time to antibiotic
therapy were derived from different data sources with-
out a fixed prioritised order.
Patients diagnosed after admission experienced treat-
ment delay and increased in-hospital mortality and un-
favourable outcome at discharge. Patients without typical
signs of CABM at admission also had treatment delay, but
in this group we found no clear differences in mortality
and unfavourable outcome. Still, as the prognosis for these
patients remain poor, a high index of suspicion of CABM
seems prudent even in patients without all the typical
signs of CNS infection.
Duration of disease may be crucially linked to dis-
ease severity and thereby outcome, but categorisation
of prodromal disease and onset of meningitis is
almost impossible in clinical settings, and even more
so in retrospective studies. Therefore, we cannot ex-
clude residual confounding although we reported data
on disease duration exactly as stated in the medical
records. Moreover, we did not see differences in
outcome according to duration of symptoms for >24
or <24 h.
Conclusion
In conclusion, delayed initiation of antibiotic therapy for
bacterial meningitis is associated with increased in-
hospital mortality and an unfavourable outcome at
discharge.
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